Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihito Tagawa

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Antimicrobial Agents and Chemotherapy|May 4, 2021
Tafenoquine Is a Promising Drug Candidate for the Treatment of BabesiosisMingming Liu, Shengwei Ji, Daisuke Kondoh, et al.
The Journal of Veterinary Medical Science|October 13, 2025
Clinical efficacy of anti-programmed death ligand 1 antibody HFC-L1/c4G12 in dogs with malignant tumors: an exploratory studySatoshi Takagi, Michihito Tagawa, Naoya Maekawa, et al.
Veterinary Sciences|September 27, 2025
Exploratory, Randomized, Dose-Response Study of the Anti-PD-L1 Antibody HFC-L1/c4G12 in Dogs with Pulmonary Metastatic Oral Malignant MelanomaKenji Hosoya, Sangho Kim, Ryohei Kinoshita, et al.
The Journal of Veterinary Medical Science|March 30, 2025
Performance evaluation of an improved RAISING method for clonality analysis of bovine leukemia virus-infected cells: a collaborative study in JapanTomohiro Okagawa, Naomi Nojiri, Hazuka Yoshida-Furihata, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Antimicrobial Agents and Chemotherapy|May 4, 2021
Tafenoquine Is a Promising Drug Candidate for the Treatment of BabesiosisMingming Liu, Shengwei Ji, Daisuke Kondoh, et al.
The Journal of Veterinary Medical Science|October 13, 2025
Clinical efficacy of anti-programmed death ligand 1 antibody HFC-L1/c4G12 in dogs with malignant tumors: an exploratory studySatoshi Takagi, Michihito Tagawa, Naoya Maekawa, et al.
Veterinary Sciences|September 27, 2025
Exploratory, Randomized, Dose-Response Study of the Anti-PD-L1 Antibody HFC-L1/c4G12 in Dogs with Pulmonary Metastatic Oral Malignant MelanomaKenji Hosoya, Sangho Kim, Ryohei Kinoshita, et al.
The Journal of Veterinary Medical Science|March 30, 2025
Performance evaluation of an improved RAISING method for clonality analysis of bovine leukemia virus-infected cells: a collaborative study in JapanTomohiro Okagawa, Naomi Nojiri, Hazuka Yoshida-Furihata, et al.
Pageof 5